AIM
SBBP

Alambic Investment Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Alambic Investment Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-54,164
Closed -$114K – 61
2020
Q3 		$114K Sell
54,164
-7,200
-12% -$24.3K 1.25% 26
2020
Q2 		$232K Sell
61,364
-400
-0.6% -$1.2K 0.58% 76
2020
Q1 		$117K Sell
61,764
-56,600
-48% -$147K 0.28% 119
2019
Q4 		$247K Buy
118,364
+74,561
+170% +$143K 0.21% 185
2019
Q3 		$105K Buy
43,803
+22,633
+107% +$60.8K 0.08% 264
2019
Q2 		$66K Buy
+21,170
New +$77.7K 0.04% 280

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Alambic Investment Management's SBBP Position: Q4 2020 in Review

Alambic Investment Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2020, closing a stake of 54,164 shares — an estimated $114K sold.

Alambic Investment Management first reported a position in SBBP in Q2 2019 and held it in 6 quarters. The position peaked at $247K in Q4 2019. 71 funds tracked by Wall St. Rank hold SBBP as of Q4 2020.

  • Alambic Investment Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 54,164 Strongbridge Biopharma plc. shares in Q4 2020, an estimated $114K.
  • Alambic Investment Management first reported a position in Strongbridge Biopharma plc. in Q2 2019 and held it in 6 quarters.
  • Alambic Investment Management's Strongbridge Biopharma plc. position peaked at $247K in Q4 2019.
  • 71 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.